🔗 Permalink

Inventor profile of:

Douglas Michael ACKERMANN

City:

Reno, Nevada

Country:

United States

Published Applications:

Last publication date:

2026-04-23

Top Assignees for applications by Douglas Michael ACKERMANN

The entities that hold a legal rights for patent applications filed by inventor ACKERMANN Douglas Michael:

Tarsus Pharmaceuticals, Inc. 10 Irvine, CA United States
Presidio Medical, Inc. 5 South San Francisco, CA United States
Oculeve, Inc. 2 San Francisco, CA United States
Presidio Medical, Inc. 2 Reno, NV United States
Presidio Medical, Inc. 2 San Mateo, CA United States
Oculeve, Inc. 2 Madison, NJ United States
OCULEVE, INC. 2 South San Francisco, CA United States
ALLERGAN / Oculeve 1 Madison, NJ United States
Oyster Point Pharma, Inc. 1 Princeton, NJ United States
The Board of Trustees of the Leland Stanford Junior University 1 Palo Alto, CA United States
Oculeve, Inc. 1 Washington, DC United States

Recent patent applications by ACKERMANN Douglas Michael

Douglas Michael ACKERMANN from Reno, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23

US20260108498A1

Human necessities

METHOD OF ERADICATING TICKS THAT ATTACH TO HUMANS USING LOTILANER FORMULATIONS

#2 | 2026-03-26

US20260083965A1

Human necessities

SYSTEMS AND METHODS FOR DIRECT CURRENT NERVE CONDUCTION BLOCK

#3 | 2025-10-09

US20250312319A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR USE

#4 | 2025-10-09

US20250312318A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#5 | 2025-10-09

US20250312317A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#6 | 2025-09-11

US20250281736A1

Human necessities

CURRENT BIAS AS A CONTROL MECHANISM FOR ELECTRODE OPERATION

#7 | 2025-04-24

US20250127762A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#8 | 2025-01-30

US20250032782A1

Human necessities

NASAL STIMULATION DEVICES AND METHODS

#9 | 2025-01-16

US20250017908A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#10 | 2024-09-12

US20240299747A1

Human necessities

ACUTE BLOCKADE WITH DELAYED NEURAL SUPPRESSION

#11 | 2024-08-01

US20240252814A1

Human necessities

NASAL STIMULATION FOR RHINITIS, NASAL CONGESTION, AND OCULAR ALLERGIES

#12 | 2024-07-11

US20240226572A1

Human necessities

PULSE GENERATION AND STIMULATION ENGINE SYSTEMS

#13 | 2024-07-04

US20240216694A1

Human necessities

METHODS AND SYSTEMS FOR NERVE CONDUCTION BLOCK

#14 | 2024-06-20

US20240198089A1

Human necessities

SYSTEMS AND METHODS FOR NERVE CONDUCTION BLOCK

#15 | 2024-06-06

US20240181261A1

Human necessities

PULSE GENERATION AND STIMULATION ENGINE SYSTEMS

#16 | 2023-09-28

US20230301971A1

Human necessities

Isoxazoline parasiticide formulations

#17 | 2023-09-21

US20230293496A1

Human necessities

Isoxazoline parasiticide formulations and methods for treating blepharitis

#18 | 2023-07-13

US20230218584A1

Human necessities

SYSTEMIC ISOXAZOLINE PARASITICIDES FOR VECTOR-BORNE AND VIRAL DISEASE TREATMENT OR PROPHYLAXIS

#19 | 2023-06-22

US20230190711A1

Human necessities

METHODS FOR TREATING OCULAR DEMODEX USING SPINOSAD FORMULATIONS

#20 | 2023-01-12

US20230008440A1

Human necessities

Current bias as a control mechanism for electrode operation

#21 | 2022-12-29

US20220409905A1

Human necessities

Pulse generation and stimulation engine systems

#22 | 2022-11-17

US20220362218A1

Human necessities

Methods for treating ocular using lotilaner formulations

#23 | 2022-11-10

US20220354830A1

Human necessities

Ophthalmic compositions for treating ocular using lotilaner formulations

#24 | 2022-11-10

US20220354829A1

Human necessities

Methods for treating demodex blepharitis using lotilaner formulations

#25 | 2022-08-11

US20220249445A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#26 | 2022-06-09

US20220176130A1

Human necessities

Methods and systems for nerve conduction block

#27 | 2022-05-26

US20220160682A1

Human necessities

SYSTEMIC ISOXAZOLINE PARASITICIDES FOR VECTOR-BORNE AND VIRAL DISEASE TREATMENT OR PROPHYLAXIS

#28 | 2022-03-31

US20220096827A1

Human necessities

Systems and methods for direct current nerve conduction block

#29 | 2022-03-24

US20220088374A1

Human necessities

Systems and methods for nerve conduction block

#30 | 2022-02-24

US20220054457A2

Human necessities

METHODS FOR TREATING OCULAR DEMODEX USING SPINOSAD FORMULATIONS

#31 | 2021-12-02

US20210370051A1

Human necessities

NASAL STIMULATION FOR RHINITIS, NASAL CONGESTION, AND OCULAR ALLERGIES

#32 | 2021-08-05

US20210236809A1

Human necessities

NASAL STIMULATION DEVICES AND METHODS FOR TREATING DRY EYE

#33 | 2021-07-01

US20210196689A1

Human necessities

Isoxazoline parasiticide formulations and methods for treating blepharitis

#34 | 2021-03-18

US20210077466A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#35 | 2021-03-18

US20210077465A1

Human necessities

ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS

#36 | 2021-02-11

US20210038101A1

Human necessities

SYSTEMS AND METHODS FOR CARDIAC CONDUCTION BLOCK

#37 | 2020-11-05

US20200345734A1

Human necessities

METHODS OF TREATING OCULAR CONDITIONS

#38 | 2020-08-13

US20200253723A1

Human necessities

PUPILLARY ACCOMMODATING INTRAOCULAR LENS

#39 | 2020-07-30

US20200238076A1

Human necessities

Nasal stimulation devices and methods for treating dry eye

#40 | 2020-04-23

US20200121181A1

Human necessities

APPARATUS AND METHOD FOR DRY EYE FORECAST AND TREATMENT RECOMMENDATION

#41 | 2020-02-06

US20200038238A1

Human necessities

IMPLANT DELIVERY DEVICES, SYSTEMS, AND METHODS

#42 | 2019-11-14

US20190344077A1

Human necessities

STIMULATION DEVICES AND METHODS

#43 | 2019-10-17

US20190314630A1

Human necessities

Systems and methods for direct current nerve conduction block

#44 | 2019-07-04

US20190201397A1

Human necessities

Methods of treating ocular conditions

#45 | 2019-06-20

US20190183862A1

Human necessities

Methods for treating ocular demodex using isoxazoline parasiticide formulations

#46 | 2018-10-04

US20180280691A1

Human necessities

Systems and methods for direct current nerve conduction block

#47 | 2018-06-14

US20180161579A1

Human necessities

EXTRANASAL STIMULATION DEVICES AND METHODS

#48 | 2018-06-07

US20180154137A1

Human necessities

Nasal stimulation devices and methods

#49 | 2018-06-07

US20180153394A1

Human necessities

Apparatus and method for dry eye forecast and treatment recommendation

#50 | 2018-03-08

US20180064941A1

Human necessities

Stimulation devices and methods

#51 | 2018-03-08

US20180064940A1

Human necessities

Stimulation devices and methods

#52 | 2017-12-28

US20170368359A1

Human necessities

Implantable device for increasing tear production

#53 | 2017-12-28

US20170368332A1

Human necessities

Nasal stimulation devices and methods

#54 | 2017-12-14

US20170354536A1

Human necessities

Implant delivery devices, systems, and methods

InventorID:

2061361 ⎘